Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06240143
Title Intradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma (MARIANE)
Acronym MARIANE
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors The Netherlands Cancer Institute
Indications
Therapies
Age Groups: senior | adult
Covered Countries NLD


No variant requirements are available.